These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34221873)

  • 41. Biosynthetic metabolomes of cysteinyl-containing immunoresolvents.
    Jouvene CC; Shay AE; Soens MA; Norris PC; Haeggström JZ; Serhan CN
    FASEB J; 2019 Dec; 33(12):13794-13807. PubMed ID: 31589826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.
    Noureddine N; Hartling I; Wawrzyniak P; Srikanthan P; Lou PH; Lucchinetti E; Krämer SD; Rogler G; Zaugg M; Hersberger M
    Am J Clin Nutr; 2022 Sep; 116(3):786-797. PubMed ID: 35849016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.
    Carion TW; Greenwood M; Ebrahim AS; Jerome A; Suvas S; Gronert K; Berger EA
    FASEB J; 2018 Sep; 32(9):5026-5038. PubMed ID: 29913556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5
    Lei J; Zhou Y; Zhao H; Chen Y; Yan G; Wu L; Xu Y; Zhang J; Zhang X; Wang J; Li D; Li Y
    Theranostics; 2021; 11(9):4251-4261. PubMed ID: 33754059
    [No Abstract]   [Full Text] [Related]  

  • 45. Chiral chromatography-tandem mass spectrometry applied to the determination of pro-resolving lipid mediators.
    Homann J; Lehmann C; Kahnt AS; Steinhilber D; Parnham MJ; Geisslinger G; Ferreirós N
    J Chromatogr A; 2014 Sep; 1360():150-63. PubMed ID: 25124229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice.
    Viola JR; Lemnitzer P; Jansen Y; Csaba G; Winter C; Neideck C; Silvestre-Roig C; Dittmar G; Döring Y; Drechsler M; Weber C; Zimmer R; Cenac N; Soehnlein O
    Circ Res; 2016 Oct; 119(9):1030-1038. PubMed ID: 27531933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice.
    Miyata J; Yokokura Y; Moro K; Arai H; Fukunaga K; Arita M
    Front Immunol; 2021; 12():687192. PubMed ID: 34093589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men.
    Vella L; Markworth JF; Farnfield MM; Maddipati KR; Russell AP; Cameron-Smith D
    Physiol Rep; 2019 Aug; 7(13):e14108. PubMed ID: 31257737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of multi-target inhibitors of leukotriene and prostaglandin E
    Gür ZT; Çalışkan B; Garscha U; Olgaç A; Schubert US; Gerstmeier J; Werz O; Banoglu E
    Eur J Med Chem; 2018 Apr; 150():876-899. PubMed ID: 29597170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators.
    Jordan PM; van Goethem E; Müller AM; Hemmer K; Gavioli V; Baillif V; Burmeister Y; Krömmelbein N; Dubourdeau M; Seilheimer B; Werz O
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.
    Lukic A; Larssen P; Fauland A; Samuelsson B; Wheelock CE; Gabrielsson S; Radmark O
    FASEB J; 2017 Oct; 31(10):4370-4381. PubMed ID: 28637652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity.
    Gagnon KJ; Lefort N; Poirier SJ; Barnett DA; Surette ME
    Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():38-44. PubMed ID: 30392579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liquid chromatography-coupled mass spectrometry analysis of glutathione conjugates of oxygenated polyunsaturated fatty acids.
    Liening S; Romp E; Werz O; Scriba GKE; Garscha U
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106350. PubMed ID: 31323323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 12-Oxo-10-glutathionyl-5,8,14-eicosatrienoic acid (TOG
    Liening S; Fischer J; Jagusch H; Pohnert G; Höcker O; Neusüß C; Werz O; Scriba GKE; Garscha U
    Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106480. PubMed ID: 33172790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS.
    Nishiokada A; Miyoshi M; Fujiwara M; Aoyama-Ishikawa M; Maeshige N; Takahashi M; Hamada Y; Usami Y; Honda M; Arita M; Usami M
    Clin Nutr; 2015 Aug; 34(4):685-93. PubMed ID: 25131602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators.
    Gilbert NC; Newcomer ME; Werz O
    Biochem Pharmacol; 2021 Nov; 193():114759. PubMed ID: 34487716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.
    Garscha U; Romp E; Pace S; Rossi A; Temml V; Schuster D; König S; Gerstmeier J; Liening S; Werner M; Atze H; Wittmann S; Weinigel C; Rummler S; Scriba GK; Sautebin L; Werz O
    Sci Rep; 2017 Aug; 7(1):9398. PubMed ID: 28839250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Oral Tributyrin Treatment on Lipid Mediator Profiles in Endotoxin-Induced Hepatic Injury.
    Miyoshi M; Usami M; Kajita A; Kai M; Nishiyama Y; Shinohara M
    Kobe J Med Sci; 2020 Dec; 66(4):E129-E138. PubMed ID: 33994516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.